Skip to content

Speech therapy in radiation therapy

Effect of Vocal Rehabilitation after Chemoradiation for Non-Laryngeal Head and Neck Cancers - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/110987
Enrollment
98
Registered
2026-05-25
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx

Interventions

Intervention1: 6 Week voice Rehabilitation Therapy: Non-Laryngeal Head and Neck Cancer Patient Who received Chemoradiation Therapy With Voice rehabilitation for 6 weeks Control Intervention1: No Voice

Sponsors

Indra Gandhi Medical College Shimla HP
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Non-laryngeal head and neck cancer (oral cavity, oropharynx, nasopharynx, or hypopharynx) confirmed by biopsy and planned for definitive concomitant chemoradiotherapy (CRT) OR Radiotherapy alone. No prior treatment (radiotherapy, or chemotherapy) for head and neck cancer. Baseline voice grade no worse than moderate dysphonia (to allow assessment of change). Adequate hearing and cognitive function to participate in voice assessments and therapy.

Exclusion criteria

Exclusion criteria: Primary laryngeal cancer or direct involvement of the Larynx by cancer of other site. Pre-existing voice or speech disorders unrelated to cancer (e.g. neurological dysarthria, vocal cord paralysis). Prior laryngeal surgery / Recurrent nerve Palsy. Patients with advanced T3 or T4 stage head and neck malignancies. Patients with initially non-laryngeal disease that has progressed to involve the larynx. Severe comorbid conditions preventing participation (e.g. uncontrolled cardiopulmonary disease). Neurological disease affecting laryngeal muscles. Inability or unwillingness to attend follow-up visits. Chemoradiotherapy defaulter

Design outcomes

Primary

MeasureTime frame
Primary Objective: To determine the beneficial effect of voice rehabilitation on subjective voice outcomes in non-laryngeal head and neck cancer patients undergoing chemoradiotherapy.Timepoint: baseline ,Mid CRT ,completion of CRP and 3 month

Secondary

MeasureTime frame
1. To evaluate changes in perceptual voice quality (using the GRBAS scale) after chemo radiation therapy (CRT) with and without voice therapy. 2. To assess changes in speech intelligibility (using a standardized Speech Intelligibility Assessment) and overall voice clarity (OVCAscore) 3. To compare the trajectory of voice recovery between patients receiving vocal rehabilitation and a control groupTimepoint: baseline ,mid CRT, completion of CRP and 3 month

Countries

India

Contacts

Public ContactDr Jagdeep S Thakur

Indria Gandhi Medical College

anujagdeep@gmail.com9418477400

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026